Good morning.
Futures pointing green — NVDA +2% premarket on the $5B SSI commitment (Vera Rubin locked in, not TPU), CDNS and RMBS grinding higher after clean prints, GOOGL flat. S&P futures +0.3%, NDX outperforming. Biggest movers: AMKR up 4% on AI CPU packaging narrative, WULF +3% on nothing in particular, while CHTR -1.5% after another cable subscriber bleed.
Earnings reactions clean across the board. CDNS: record $8.1B BACKLOG in a low-renewal year, core EDA growth 18% — that’s design consumption expanding, not billing timing. RMBS: product rev $99.2M (+22% YoY), Q3 guide $110-116M, above consensus. Memory-interface content growth outpacing server units (~12%). Samsung potentially POSTING THE HIGHEST QUARTERLY PROFIT EVER BY A GLOBAL TECH COMPANY — HBM margin expansion doing the heavy lifting.
Asia digesting the China DUV lithography story. State-backed production started — 5 units in 2024, 20 by 2027. ASML down <1% premarket. BofA calls it a “modest threat,” and they’re right: throughput, overlay, ecosystem maturity are years behind. But the rate-of-change debate matters — how fast does China iterate from 5 to 20 to 200 units?
Three themes framing today:
First, China DUV: strategic noise, not structural threat. Having a tool doesn’t mean matching defect rate or throughput. Canon and Nikon have DUV tools too. The path to $300B+ WFE by 2030 unchanged — domestic tools are additive, not substitutive. ASML still the monopoly at scale.
Second, NVDA’s circular finance debate intensifies. $750B deal pipeline (Hynix $500B, OpenAI $250B, SSI, Thinking Machines) — is this demand validation or vendor-financed bubble? SSI’s shift from TPU to Vera Rubin locks in a frontier lab on next-gen silicon, but the “Fannie Mae” analogy from Twitter is sharp: NVDA provides wallboard AND the mortgage. Watch the bond market reaction.
Third, EDS & custom silicon proliferation is a slow-rolling regime change. CDNS backlog confirms hyperscaler design count accelerating — each CSP pursuing multiple workload-specific chips (training, inference, networking, storage). Near-term bull for AVGO, MRVL, CDNS. Long-duration risk for merchant GPU share. ASIC enablers win, period.
Fourth, Memory: the bear case has the sign wrong. Kimi K3’s KV cache compression makes NAND offload viable at scale — that’s a memory demand positive. Samsung’s record profit is real. And GOOGL GCP print (82% YoY, ~79% ex-Wiz) is the first hard evidence this capex cycle clears an ROI hurdle.
We’ll hit up CDNS, RMBS, and ASML first, then get to semis and networking — AMKR, AVGO, MRVL, FORM all on the desk.
Verdict: First-day analyst love story on ITG — six initiations, all bullish, PT range $16-$19, median ~$17. Stock at $13.46, so 26-41% implied upside. Market isn't buying the narrative yet (down 24% YTD vs IPO at $16, opened $18). That's the setup. Either the analysts are early, or they’re wrong.
Street is uniformly long. Six firms — Morgan Stanley ($19), Baird ($19), UBS ($18), KeyBanc ($17), Stifel ($16), BofA ($16) — all lead with a single bet: ITG is Dycom (DY) but smaller, cheaper, and earlier in the roll-up story. The core thesis hangs on four hooks:
Bull case: ITG is a compounder disguised as a contractor. The FUSE360 software creates real cost advantages, M&A is disciplined and accretive, and the end-market demand is structural — not cyclical. At 8.5x 2027 EBITDA with 15%+ organic growth (MS sees 15% CAGR over 5 years), the discount to DY is unjustified. If ITG simply trades in line with DY at 12x, that's a 40%+ rerating. UBS sees 40% upside from here: "growth from digital connectivity markets and company-specific initiatives are not priced in."
Bear case: Customer concentration is horrid — top two customers are 60-67% of revenue. That's single-point-of-failure risk, especially if one is a cable MSO pulling back on capex. ITG is unprofitable LTM (negative net income), and Oaktree controls the board — overhang risk. The sell-off in E&C names wasn't random; the market is pricing in execution risk on BEAD deployment delays or a slowdown in data center fiber builds. At 8.5x, the discount to DY exists for a reason: lower scale, less diversification, less liquidity. Not sure we can read too much into initiations — they're all new coverage, not upgrades or earnings beats.
Everything here is new — all six analysts initiated today. Nothing from prior coverage because ITG just IPO'd (priced $16, opened $18, current $13.46). The incremental signal is the unanimity and the magnitude of the discount argument. No one came in bearish. No one said "wait and see." That's unusual for a $1.5B market cap name with thin float and one quarter of trading history. The risk is that these initiations are all "housekeeping" from syndicate desks.
The strongest incremental data point: 22 M&A deals since 2019 with sub-3x post-synergy multiples. That's a repeatable capital allocation model, not a one-off.
Peers: Dycom (DY) is the direct comp — ITG trades at a 30%+ EBITDA multiple discount. If the bull case plays out, DY multiple should hold or expand as the sector gets re-rated for recurring revenue. MasTec (MTZ) and Quanta Services (PWR) are larger, more diversified — ITG is a purer fiber play. Baird and Stifel both point to DY as the closest peer.
Thematic: The entire broadband infrastructure complex is being repriced post-IPO. ITG's offering was a litmus test for investor appetite for fiber buildout stories in a rate environment that's still uncertain. The weak aftermarket (down 24% from first trade) suggests institutional buyers are skeptical. These initiations are a coordinated push to change that narrative. Watch for insider selling lockup expirations and Oaktree's next move.
Verdict: The cable narrative is broken. 172k broadband losses and a -4.3% EBITDA print have every analyst tearing up their models. The stock sits at $126, down 60% in a year, and the only thing left to argue about is whether it’s a value trap or a generational entry point. PTs now span a ridiculous $140-$380 range — that’s not debate, that’s confusion.
Revenue in-line ($13.5B vs $13.52B consensus), but everything underneath turned to ash. Broadband net losses of 172k blew past the 145k bogey. ARPU fell 1.7% YoY — 1.1% below where the Street had it. EBITDA down 4.3% YoY, and core EBITDA (ex transition costs) is now expected to decline ~1% for the year vs prior expectations of growth. FCF of $1.0B missed by 12%, though the TTM FCF yield screams 26% — the kind of number that usually gets event activists circling. CapEx was $2.9B, 3% above consensus, because they’re still shoveling money at network upgrades. Buybacks were $838M vs $1B consensus — management is pulling back on repurchases as EBITDA shrinks.
Bright spots: mobile adds of 406k beat the 375k estimate. Video losses of 21k were way better than the 64k feared. Cox deal closes next month, with $800M+ in run-rate savings promised. But none of that matters when the core product is bleeding customers.
"The challenges facing Charter today are the same ones the combined company will face. Lower pricing has rarely proven sufficient to drive sustainable growth in a mature and increasingly competitive broadband market." — Bernstein SocGen
Seven firms updated targets. The cluster is ugly:
The Bull Case (BofA, Cowen): At 5.3x EV/EBITDA and 3.2x P/E, the stock already discounts a worst-case scenario. Clear broadband stabilization and CapEx decline would unlock a massive re-rating. Cox adds scale and $800M+ in savings — that’s real EBITDA flow-through. The free cash flow yield is 26% today. You don’t need revenue growth for that to compound. Management is open to wholesale deals with Starlink (not conceding defeat, just optionality). TD Cowen still sees a resting place for subscriber losses. Verizon’s earnings call was highly dismissive of Starlink’s US broadband opportunity — that matters for competitive sentiment.
"Charter’s current market valuation appears to discount limited benefits from Cox, convergence, lower leverage or the coming free cash flow inflection." — BofA
The Bear Case (UBS, RBC, Bernstein): Every quarter the narrative gets worse. Broadband losses are accelerating sequentially and YoY. Fiber expansion, FWA, and now Starlink are all taking share. ARPU is declining because Charter has to discount to retain subs. EBITDA is shrinking — expected to be down ~1% in 2026, but that’s assuming advertising tailwinds and no further deterioration. Management talked down prior EBITDA growth expectations. The Cox deal doesn’t solve the competitive problem; it just makes the company bigger with the same headwinds. The tax on leverage is manageable, but until broadband stabilizes, multiple expansion is a pipe dream. UBS: "Competitive dynamics will limit upside despite shares at low end of historical valuation."
CHTR is the canary in the coal mine for the entire cable ecosystem. If the largest pure-play cable operator (outside Comcast) is bleeding broadband subs at 172k/quarter, the “cord-cutting but broadband is sticky” thesis is under direct assault. Expect CMCSA to get more scrutiny on its broadband trends when they report. T and VZ are the winners here — FWA is still soaking up share, and both are signaling aggressive pricing. Starlink is still small but growing fast in rural — every quarter it becomes more of a factor in the TMT narrative. For portfolio managers: this is a “show me” setup. The valuation is cheap for a reason, and the reason is getting worse before it gets better.
THE BUY-SIDE PIVOT ON MSFT THIS WEEK IS NOT ABOUT THE NUMBERS—IT'S ABOUT THE SIGNAL IN THE CAPEX. Three firms out with notes, and the consensus breaks cleanly: bulls see a platform shift to an AI OS, bears see a CapEx cycle that markets won't forgive.
Mostly constructive, but UBS is the one that matters here.
Benchmark (Buy, $525) and Cantor (OW, $502) are repeating themselves—same PTs, same thesis. They're not wrong, they're just not new. Cantor's math is worth noting though: MSFT at 18X C27 EPS vs a 3yr median 30X and S&P at 20X. That's a trough multiple. The stock is pricing in an AI bust, not a build.
The real signal is UBS cutting to $480 from $510. Kierstead did channel checks—a DOZEN customers and partners. That's primary intel, not a model tweak. He flags capacity constraints on external customers + early token optimization eating into Azure's incremental dollar. The kicker: "capital expenditure estimates could move higher due to demand and memory inflation." He then drops an uncomfortable precedent—Oracle and Google got smoked when they signaled higher CapEx without cloud revenue upside.
"Azure and AWS demand appears to be healthy…though, capacity constraints on external customers and early token optimization efforts could limit potential for material Azure guidance upside." — UBS
This is the tension. Demand is real. The supply side is getting pinched by self-inflicted bottlenecks (replacing OpenAI image models in-house is strategically smart, tactically costly). And the macro backdrop for CapEx-rich stories is horrid right now.
BULL (Benchmark, Cantor): MSFT is transitioning from "frontier AI partner" to "AI operating system and orchestration layer." The multiple compression is an entry. PEG of 0.76. This is a 10-year infrastructure build trading like a hardware cyclical.
BEAR (UBS, implicitly): The market is not rewarding AI infrastructure bogeys. Token optimization is a headwind to Azure consumption growth, not a tailwind. CapEx keeps going up, free cash flow yield keeps getting pinned lower. MSFT is trading at 22.9X earnings—that's not cheap if the growth rate decelerates from here.
The July 28 print matters less than the guidance. Specifically: Azure growth rate, commentary on enterprise Copilot adoption curves, and—most importantly—whether CapEx gets raised again. If it does, the UBS thesis gets validated. If Azure accelerates AND CapEx is contained, short-term bears get run over.
My take: MSFT at $383-392 with a 22.9X multiple is pricing in a lot of bad news. The bull case here doesn't need a beat—it needs a narrative that CapEx is generating ROI. That's a long-cycle story, but the entry is the most attractive it's been in years for a 10%+ revenue grower with 68% gross margins. Short-bias PMs can lean on the print volatility. Long-bias PMs should be building a position into the weakness.
Verdict: Slightly bullish on risk/reward. The UBS cut is a real risk factor, but the multiple is already pricing in a lot of that theater of pain.
Verdict: INTC delivered a monster beat. The question is whether the stock has already run too far to get long from here.
Revenue of $16.1B — $1.8B ABOVE THE GUIDANCE MIDPOINT, +25% Y/Y. Adjusted gross margin 41.8%, 280bps ahead. EPS printed $0.42 vs $0.20 guidance and $0.22 consensus. This isn't a squeaker — this is a 12% revenue beat and roughly 2x on the bottom line. The DC&A segment up 59% Y/Y. AI-driven businesses now ~70% of revenue.
Analysts across the street are raising numbers, but the ratings are stuck at Neutral/Hold/Market Perform across the board. That's the rub. DA Davidson goes to $100 (from $77), Bernstein to $110 (from $100), Stifel actually cut its target to $110 (from $120) on valuation. Stifel is the honest one here — they're saying what everyone is thinking but not acting on.
THE QUARTER AT A GLANCE: Operating margin beat by ~610bps. Foundry losses narrowing on better 18A yields and cycle times. CEO Lip-Bu Tan getting credit for the cultural shift and free cash flow improvement. But the core debate isn't about execution — it's about how much of the turnaround is already discounted at $485-500B market cap.
"The most important 14A catalyst, a signed external foundry customer, has not yet arrived."
That's the gap between $100 and $125+ right there. Everything else — the beat, the margin expansion, the DC&A growth — is already in the stock. The next leg higher requires that customer win, and it hasn't materialized yet. Tight supply (Baird at $125, TD Cowen at $115) is a near-term positive, but client revenue falling below seasonal in 2H is a risk worth watching.
Worth noting: Cantor Fitzgerald actually cut to $125 from $150, flagging server CPU market share losses AND equity raise speculation. That's two headwinds the bulls aren't talking about.
Bottom line: INTC is a story stock in a good way right now — execution is backing the narrative. But at 8x EV/sales (Bernstein's methodology) and TSMC-like multiples, you need the next catalyst in hand, not just hope. Position size accordingly.
Verdict: Qualcomm is a show-me story trading at 16x below-consensus CY27 EPS – and the July 29 print is the final chance to stall the narrative rot. Both sides agree on a near-term beat. The divergence is entirely about the forward guide and whether DragonFly actually changes the revenue trajectory.
Two takes, same premise. Benchmark (Buy, $300 PT) sees the June quarter as messy on handsets but views Auto/IoT/QTL as modest offsets. Cantor (Neutral, cut PT to $200 from $220) says the June quarter marks the relative bottom for China Android, but still sees CY26 handset revs tracking down 22% to $21.9B vs. consensus of $22.0B. They pencil in CY27 EPS trending to ~$11 vs. consensus $11.40. The difference is ~$100 of PT on the same back-of-napkin: Benchmark at ~27x, Cantor at ~18x.
The bull case (Benchmark): Stick with the $300 target because the data center pivot is real and the stock is already pricing in the handset drag at 18.4x trailing. The dividend hike (now $0.92/qtr) provides a floor. Options imply an 8.2% move post-earnings.
The bear case (Cantor): At 16x below-consensus CY27, you're paying up for a narrative that hasn't delivered revenue. Price increases (double digits starting Sept 1) help margins but signal end-market weakness, not demand. DragonFly is a 2029 story, not a 2026 catalyst.
"We expect Qualcomm to report a beat for the June quarter followed by a September quarter guide modestly above consensus. We believe the June quarter will mark the relative bottom for China Android... Focus is on the new DragonFly Data Center portfolio and we see a bias modestly higher for the stock trading at 16x our below-consensus CY27 EPS estimate." – Cantor Fitzgerald
Bottom line: The street is short positioning and long hope. A beat + in-line guide gets you $5-$10. A guide that confirms the dragon is awake gets you the multiple re-rating the Bulls want. Anything else and you're back to 15x on shrinking handset revenue. Not much room for error.
AMD stepped on stage and did something rare — actually expanding the TAM narrative in a way that holds water. The 2030 data center accelerator TAM got bumped to ~$1.4T (45%+ CAGR), server CPU to ~$220B (50%+). That's not incremental tweaking. That's a wholesale re-rating of the opportunity set.
The Helios rack system (MI455X) going to full production is the real signal. This isn't just a chip company anymore — AMD is selling the full stack, annual cadence (Helios 500 in 2027, 600 in 2028). They disclosed 14 gigawatts of committed compute. Stifel maps that to ~$245B cumulative revenue at $17.5B/gigawatt. The numbers are large enough to force a re-think.
Multiple firms raised PTs into the $540-$1,250 range post-event. Consensus is building around the idea that the "second source" narrative is over — AMD is becoming an architectural alternative, not a discount option.
Bull case (Stifel, Baird, Melius, UBS): The TAM expansion + annual rack cadence + open standards approach = structural share gains. The Anthropic partnership (2GW deal, potentially $17B in revenue by 2027) shows hyperscale/AI lab conviction. Stifel thinks the >$20 adjusted EPS target is "conservative." Baird sees $147B in AI GPU revenue by 2030 at just 15% share. UBS says EPS could hit $30 by 2028.
Bear case (William Blair, anyone looking at the P/E): 178x trailing is pricing in perfection. 233% return in 12 months means the narrative is fully owned. William Blair puts it cleanly — "the current valuation embeds increasingly high expectations with little room for error." Execution risk on Helios ramp is real, and annual cadence means no breather for margin improvements.
"Stifel views the company's longer-term adjusted earnings per share target exceeding $20 as a conservative floor."
The rub is simple: AMD is proving they can compete in systems, not just silicon. The question PMs need to answer is whether the $856B market cap already bakes in 2030 TAM share assumptions that would make NVDA blush. The event expanded the addressable pie, but the stock's multiple expanded faster.
Verdict: The gas turbine cycle is still early, but the stock is pricing in a lot. Jefferies stays bullish at $1,210 (Buy), Mizuho is the lone holdout at $949 (Neutral) with the stock already 7% above that. The bull case is simple — orders are exploding, capacity is being added, and 2030+ demand is real. The bear case? The Q2 EPS miss was ugly, and Mizuho thinks the stock already bakes in data center demand through 2034. Pick your timeframe.
Mixed but the top-line momentum is undeniable. Revenue of $11.1B beat by ~$370M, orders surged 88% to $24.2B, and backlog hit a record $176B. The EPS miss ($2.47 vs $3.04 consensus) is the fly in the ointment — likely cost push on capacity expansion. Guidance raised for revenue ($45.5-46.5B) and FCF ($11.5-12.5B). That’s the playbook: invest now, harvest later.
Analyst actions are clustering: Guggenheim to $1,450 (Buy), Oppenheimer to $1,338 (Outperform), Jefferies holds $1,210 (Buy), Mizuho to $949 (Neutral). The spread is massive — $949 to $1,450 — signaling real disagreement on terminal value. Everyone agrees on the next 2-3 years. The debate is 2030+.
Bull: Gas turbine demand stretches through 2030 and beyond. GEV is adding 30GW of OEM capacity to meet the wave. The electrification and data center buildout is structural, not cyclical. Strong FCF funds next-gen tech that will offset the eventual OEM deceleration. Jefferies: "GE Vernova plans to increase gas original equipment capacity to 30 gigawatts. The expansion addresses mid-2030s oversupply concerns while reducing risk in converting service opportunities."
Bear: Mizuho’s take — the stock already prices in elevated data center sales through 2034. The Q2 miss suggests margin pressure from the ramp. At $1,015 and a $270B market cap, the r/r is compressed. The Neutral rating with a $949 PT is a polite way of saying “you’re paying for perfection.”
Hard to ignore a PT that’s below the current price. Mizuho’s logic is clean:
"The stock prices in elevated data center sales through 2034."
They lifted estimates on higher pricing and electrification growth, but kept the rating unchanged. The implied message: great company, bad entry. The other analysts obviously disagree. One camp sees a multi-year super-cycle, the other sees a stock that’s front-run the story.
Verdict: A mess of conflicting signals. Leadership exit + robotaxi pivot = no one knows what this thing is worth. The bulls see floor value at $7.50; the bears see an OEMS-less future. Consensus: range-bound until new CEO gives a roadmap.
Mobileye crushed Q2 – EPS of $0.19 vs $0.06 consensus, revenue $508M vs $482M, guide to ~$2B FY revenue. None of it matters. The stock got cut in half over the past year, then sold off another ~20% post-call when CEO Amnon Shashua announced he’s stepping down (staying on board).
Bull: Direct robotaxi deployment cuts out the OEM middleman – Mobileye controls its own adoption curve. The Q2 beat plus tax credit (~$0.19 EPS) provides cash runway. At $7.50, you're buying the option on physical AI at liquidation value.
Bear: Losing Shashua removes the strategic visionary. Chinese rivals (Horizon Robotics, others) are eating ADAS share. VW is a single customer dependency. Robotaxis are capital-intensive and years from profitability – and that's if regulators play ball.
"Mobileye is seizing control of its own destiny through the direct deployment strategy." – Piper Sandler (the upgrade call)
Bottom line: If you think the robotaxi pivot is bold, buy the dip with Piper. If you think it's a Hail Mary while the core business erodes, stay away. Either way – wait for the new CEO's first real communication before sizing up.
Two Buy ratings on QBTS this morning, but only one is really about the company. Stifel's reiteration carries more weight — they're anchoring on a real customer deployment with measurable results. Benchmark's initiation is a sector call masquerading as a stock call (more on that below).
Shares at $18.79, targets in a $22-$45 range. Stock is DOWN 34% over the past six months. That's a lot of pessimism for a name with a blue-chip telecom writing checks.
AT&T expanded its existing D-Wave relationship, and this one has teeth. They're integrating annealing systems into tools powering AT&T's agentic AI. The early workload result is staggering — PROCESSING TIME FROM ~1 HOUR TO UNDER 15 SECONDS. That's not theoretical. That's production.
Scope is widening too: outage detection, technician routing, network build planning, traffic management. And a gate-model evaluation path for quantum security/communications. AT&T is essentially backdooring into quantum across their entire network ops stack.
Stifel nailed the framing — this is "a validation point for D-Wave's annealing technology and an industry traction proof point." The blue-chip logo matters more than the dollar amount (which wasn't disclosed).
Benchmark's initiation is smart but less stock-specific. They released a whole industry primer ("Truths & Fiction in Quantum Compute") and essentially said: this isn't winner-take-all, take a portfolio approach. Their $30 PT is the low end of the range ($22-$45 consensus).
The timing makes sense — they're leaning into "fault tolerance momentum" and the narrative that quantum advantage is transitioning from theory to applied. But this is a sector bet dressed as a stock call. Not wrong, just less actionable.
Bull case: AT&T as an anchor customer changes everything. Real workload, real speed improvement, real expansion roadmap. The gate-model simulator launch in September adds a catalyst. Mizuho at $35 is incrementally positive on the gate roadmap through 2032.
Bear case: Revenue isn't disclosed. No path to profitability. Stock is 34% off highs and the sector has been a graveyard for momentum chasers. NSF grant ($1.6M) and exchange listing transfer (NYSE→Nasdaq) are noise, not signals. Not sure we can read too much into a single customer deployment, even if it's AT&T.
"This is a validation point for D-Wave's annealing technology and an industry traction proof point, with a blue-chip U.S. telecom operator applying the technology to real business problems."
Stifel said it best. The market has been punishing QBTS along with the rest of the quantum basket. A production-level AT&T workload that delivers 100x speed improvement is the kind of data point that forces a repricing. Worth watching the gate-model catalyst into September.
NEUTRAL INITIATION FROM ROTHSCHILD REDBURN, PT $12.88. Stock at $10.75 (~20% upside). Not exactly a ringing endorsement — it’s a “we see the potential but can’t time the catalyst” call.
The firm acknowledges IQM’s position: largest contract share by volume among quantum peers, €30M rev in FY25 (second only to IonQ), growing 91% YoY to $36.81M LTM. Vertically integrated — QPU design, fab, system software, compilers, cloud. Roadmap targeting 1,000+ logical qubits by 2030s. That part of the story is clean.
But the path to profitability is not. Rothschild projects >100% revenue growth in FY26 and ~70% CAGR through 2030, but EBITDA margins stay negative through the decade as R&D burns cash. The firm is honest about the timing problem:
“While we are positive on the direction of travel for quantum computing, we are less clear on the timing of a ’ChatGPT moment’ for the industry.”
BULL CASE: The only pure-play quantum name with meaningful revenue, a lead in contract backlog, and a scalable superconducting architecture. If the “ChatGPT moment” hits, multiples explode.
BEAR CASE: No one knows when that moment arrives. In the meantime, IQM is burning $55M+ EBITDA per year on a ~$2.9B market cap. Dilution risk real — recent warrant exercise (577k shares) and insider selling by senior manager Juha Hassel (~€2.6M worth of shares) don’t scream conviction.
Other noise: selected by LUMI AI Factory to deploy a 150-qubit system in Finland by 2027, acquired Quantistry’s simulation IP, and picked as HPE collaborator for hybrid classical-quantum platform. All good strategic moves. None change the timing calculus.
Bottom line: PT implies a modest 17% upside but the stock has traded with high volatility (InvestingPro flagged). Risk/reward is okay if you believe in the thesis, but the analyst is basically saying “we’ll know when we know.” Not a slam dunk, not a disaster. Pass for now.
Price cuts without thesis cuts. Three firms lowered PTs (Benchmark $280, UBS $235, TD Cowen $260, KeyBanc $250) — all maintain Buy or Overweight. The stock is down 30% in the past year, now $179. That’s the setup: valuation compression, not fundamentals deteriorating.
Q2 EPS beat by $0.27 ($2.85 vs $2.58 consensus). Revenue $22.79B — slight miss. EBITDA ~1% above, boosted by >$130M in one-time vendor credits (UBS flagged that). Account net adds beat. ARPA +2% to $152.91. ARPU +3.7% ex-US Cellular. Gross margin 62.45%. Strong pricing power is real.
BUT — management held full-year guidance on EBITDA and account growth. That’s the departure: TMUS historically raises. They didn’t. Benchmark flagged accelerated churn from legacy plan phase-outs. Q3 account adds guided to ~250K vs Q2’s 277K. Not a disaster, but a deceleration.
Valuations look cheap on the surface: 6.3x 2027E EBITDA vs VZ 6.2x, T 6.3x. Free cash flow yield ~11.5% (8.7x FCF). That’s not screaming "screaming buy" — it’s saying the market is pricing in zero growth or a catalyst failure.
From UBS (the firm with the most detailed thesis):
"T-Mobile shares now trade at 6.3 times 2027 estimated EBITDA and 8.7 times free cash flow. Those multiples compare to 6.2 times and 7.1 times at Verizon and 6.3 times and 7.5 times at AT&T."
Translation: TMUS is being valued in line with the legacy carriers despite growing faster. Either it’s a value trap or the market is missing the compounding. The next catalyst is Q3 churn print — that’s where the story pivots or breaks.
Verdict: Another clean beat-and-raise from the fintech services stalwart. Organic revenue acceleration to 7.6% is the headline — not just the 2% top-line bogey. DA Davidson keeps Buy at $96 (unchanged PT), Needham at $90. The stock hasn't re-rated yet, but the rate of change is improving.
Bull case: Fintech back-office consolidation story intact. Organic momentum is picking up, margins are sticky, and the stock still trades at a discount to SaaS peers. DA Davidson says "undervalued" — the platform's Fair Value work backs that. If the 7-8% organic growth sustains, PTs should migrate higher.
Bear case: PT unchanged at $96 tells you the upside is capped after the run. No multiple expansion catalyst in sight. Leverage is still a concern (SSNC carries debt from the M&A spree), and rate cuts might not juice the business as fast as bulls hope. Also, $90 from Needham is a low bar.
Consensus is moving higher but the debate is far from settled. Two firms raised PTs this morning — Scotiabank to $52.50 (Sector Outperform) and Bernstein to $47 (Market Perform) — both citing the same underlying dynamic: Verizon’s service revenue growth is accelerating, margins are inflecting, and management just raised full-year guide. Stock is $46.38, up nearly 20% YTD. That’s a 6.1% yield and a 12x P/E. Not priced for catastrophe.
Both shops are buying the operational turnaround story, just at different conviction levels. The common thread: mobility & broadband service revenue growth hit 2.8% YoY in Q2, postpaid phone net additions of 184k beat expectations, and Q2 EPS of $1.30 printed above the $1.28 bogey. Management raised 2026 service revenue and FCF guidance. Churn is improving — go-to-market changes are finally showing up in the numbers.
Scotiabank raised second-half ’26 and ’27 estimates, projecting cumulative margin lift from lower subsidy intensity and a more converged model. They want to see better net account adds — that’s the missing piece to sustain revenue momentum into next year.
Bernstein bumped EPS estimates for FY26 and FY27, citing better-than-expected EBITDA margins and free cash flow. They also flagged an increased buyback program. Still, the $47 target is barely above the current price — the rating stays Market Perform.
“Management is delivering significant improvement in margins and the go-to-market strategy is starting to provide better churn outcomes. ... The cumulative effect of better churn management, lower subsidy intensity, and a more converged go-to-market model should support a more sustainable growth run-rate.” — Scotiabank
Bull case: The operating leverage story is real. Margins expanding, cash flow accelerating, dividend safe (21 years of raises), and the stock still yields 6%+ at a discount to history. If net account adds reaccelerate in H2, the $52.50 target is in play.
Bear case: Revenue still missed Q2 ($34.3B vs $35.28B consensus). The H2 guide requires a massive step-up in postpaid adds to hit the upper half of the target. Bernstein’s $47 PT says upside is capped. At 12x earnings and ~20% YTD, the easy money might be done. The r/r flips from “recovery” to “execution.”
Upgrade to Accumulate from Neutral at Phillip Securities — but PT trimmed to $425 from $450 (stock at $319.74, -9% in the week, +66% last year). The thesis: AI-driven revenue acceleration more than offsets the FCF negative quarter. Ad growth +14% y/y on Gemini integration + Shorts/CTV monetization. Cloud? +82% y/y — fastest in years. P/E 16x, PEG 0.14. That's cheap for 20% trailing revenue growth.
The FCF bleed is the headline scare, but Phillip explicitly calls it "temporary" — AI capex creating longer-term revenue visibility. They shaved FY26 revenue/NI by 2% and 4% on supply chain headwinds, but the upgrade says the r/r is skewed positive at these levels.
"Alphabet’s vertically integrated AI ecosystem spanning custom silicon, optimized data centers, and Gemini models provides a durable competitive moat." — Analyst Serena Lim Yi Qi
Other sell-side noise you should know (because consolidation matters): Bernstein cut PT to $385 (Market Perform) on FCF miss. Barclays stayed at $425 (Overweight) — they like the TPU-as-a-service model. Citizens remains at $515 (Outperform) — most bullish on AI monetization path. The range is wide ($385-$515), but the median is north of $425. No one is bailing.
Bottom line: Upgrade on rate-of-change improvement in cloud/ad. The FCF negative quarter is a speed bump for bearish narratives, not a structural break. At 16x earnings and a PEG <0.2, PMs who can stomach the capex guidance (new range $195B-$205B for 2026) get a vertically stacked AI story for free.
Oppenheimer stays Outperform with $200 PT into Aug 3 print. They’re modeling Q2 rev growth ~85% YoY — well above the 79% midpoint guide. Expect full-year guidance to get lifted to 75%+ from 71%. Gov side is humming (US low 80% growth, DHS + Middle East tailwinds), and US commercial is the real monster at 135%+ YoY. International gov is the weak link as European allies look for alternatives.
“Oppenheimer expects Palantir to report approximately 85% year-over-year revenue growth for the second quarter, exceeding the company’s midpoint guidance of 79%.”
The bull case is de-risked: Palantir apparently didn’t see the deal delays that hit other software names in Q2. Bear case is still multiple (trades at 12x forward sales on $295B mkt cap) and the international gov slowdown — but the print is the catalyst. Watch the guide raise.
CANTOR REITERATES OVERWEIGHT, $725 PT — thesis is simple: AI-powered attacks like the Hugging Face breach (17,000 actions across ephemeral sandboxes with self-migrating C2) is exactly the kind of threat that legacy endpoint-only tools can’t track. Cantor sees a structural demand shift toward platforms with broad telemetry — not just CRWD, but also PANW and ZS. The Hugging Face incident is a concrete proof point: they used their own AI to catch it, but most shops don’t have that. Expect the “agentic attack” narrative to get louder.
“Tools limited to monitoring a single endpoint or network segment would struggle to detect such activity.” — Cantor on why multi-stage, multi-surface attacks favor Falcon’s cloud-native graph.
Bottom line: CRWD is the incumbent for this theme. The PT implies ~40% upside from here. Risk is execution (July outage still fresh), but the rate of change in threat complexity is on their side.
Hailo AI acquisition is a strategic fit but a financial non-event. MCHP buying the private edge AI accelerator shop – terms undisclosed, no material near-term impact. Stifel stays Buy / $108 (36% upside from $78.86). Cantor also Overweight at $125, pointing out MCHP is the laggard in analog and INVESTOR POSITIONING IS UNDERWEIGHT – that's the setup. But J Capital threw cold water: data center is only ~7% of revenue, and the AI narrative doesn't move the needle there yet. Product news (free compilers, rad-tolerant clock gen) is background noise. The Hailo deal buys optionality on intelligent edge, but the stock needs more than a press release to re-rate. Near-term model unchanged.
Verdict: ServiceNow is the AI platform story that keeps delivering. Q2 beat on both revenue ($3.99B vs $3.93B) and EPS ($0.90 vs $0.86), subscription revenue guidance raised, and AI ACV is "continuing to surpass expectations" — that's the key signal.
Thesis: D.A. Davidson reiterated Buy with $170 PT, revising estimates higher. They see conservative guidance as a setup for beats. The broader analyst community echoes this: Cantor at $141, Oppenheimer and Citizens also positive. The narrative is AI-driven acceleration in the core workflow platform, and the rate of change is positive. The only debate is upside to the $1.5B AI ACV 2026 target — looks like they'll smash it.
"AI annual contract value continues to surpass expectations."
Benchmark stays a Hold. Mark Zgutowicz isn't budging. His beef? The gap between Meta's AI compute ambition and the reality of available next-gen silicon. The stock shed 7.8% into the print ($603), and he's not convinced the July 29th report will bridge that divide. He's got five questions prepped for management — the whole note is around ROIC uncertainty at a 2.88x PEG.
"Aspiration and reality are increasingly diverging, particularly regarding compute capacity."
The market's pricing in a straight line to $1T+. Zgutowicz is saying the capital expenditure glide path might not cooperate. Low/base/high CapEx scenarios matter less when your 2026-2027 gigawatt targets feel aspirational vs. actual supply chains. ROIC is 25% — fine — but the r/r here is about rate of change on that number, not the level.
Bull case is intact and getting stronger. RBC just lifted PT to $227 (from $207) after DLR cleared the 2Q26 bar on all metrics — and more importantly, laid out multi-year double-digit FFO growth visibility that extends cleanly into 2027. The Blackstone NoVa assets drip NOI gradually through 1H27, and asset recycling tilts to 2H26 via a new stabilized hyperscale fund. That’s not a one-quarter beat; that’s a structural re-rate signal.
"Double-Digit Core FFO Growth Visibility Extends Into 2027… management is confident of annual double-digit percentage Core FFO/sh growth on a multi-year basis, with 2026 guidance of $8.15-$8.20 (+10% CC) and similar visibility into 2027." — RBC Capital
TD Cowen upgraded to Buy from Hold on record demand. Citizens stays Market Outperform at $250. Even Bernstein held Outperform on the quarter (trimmed PT to $226 from $232 — rounding error). KeyBanc is the lone neutral, but that’s a Sector Weight, not a sell. The collective message: DLR is executing into the strongest demand cycle in data center history, and the financials are starting to reflect it. Trade the FFO growth narrative, not the headline multiple.
Stifel is staying bullish — reiterating Buy with a $106 PT (41% upside) — and the thesis is all about the chip roadmap. The firm sees the 5nm CV72/CV75 ramp and the upcoming 4nm CV7 (production by end FY27) as the catalysts, with the heaviest R&D spend now behind them. That sets up operating leverage: revenue growth outpacing opex growth, plus a massive ASP step-up from the current $15 blended level as each new generation hits. The 2nm CV8 production in 1H FY28 is the longer-term kicker.
"The heaviest research and development investment largely behind the company."
The bull case gets support from the $800M Hanwha deal over ten years, 28% LTM revenue growth, 59% gross margins, and a beat-and-raise quarter (EPS $0.11 vs $0.10 consensus). Eight analysts have revised estimates up recently. The PT cluster runs $80-$120, with Stifel at the high end — not alone, Rosenblatt at $120 and Northland at $101. The bear case? BofA is Neutral at $96, likely worried about execution risk on the new nodes and end-market concentration. But the rate of change in edge AI shipments (46M+ SoCs shipped, 200+ AI models supported) is hard to ignore. The signals here are constructive, but this is a multi-year story — not a three-month whip.
BUY INTO THE PRINT. Cantor stays Overweight / $400 PT (43% upside from $269), sees a modest beat and solid raise next week. The bar is low after TXN and STM both disappointed — positioning is light, so a clean quarter could rip the stock. They think CY27 EPS power is tracking ABOVE $18 vs consensus $17.66, with company-specific growth drivers compounding from here.
“We continue to expect NXPI to post a modest beat and a solid raise next week with Auto tracking better-than-expected, demand strength broadening, and a secular growth story which remains well intact.” — Matthew Prisco, Cantor Fitzgerald
Auto semis are the key swing factor. People are spooked by Analog weakness (TXN’s guide was horrid), but NXPI’s auto exposure is different — more content per vehicle, less commodity drag. If management confirms broadening demand beyond Auto (Industrial, IoT), that’s the catalyst. $400 PT looks aggressive vs $269 spot, but in a multi-manager book this is a high-conviction r/r into earnings. We’d be buyers here.
BofA is pounding the table on ASML post-puke. Maintains Buy, calls the 18% SOX underperformance since peak a garden-variety correction — not a structural breakdown. They map it to 2015 (China slowdown) and 2018 (trade war), which saw 17% and 17% drawdowns respectively. The bet: this is a buying opportunity, not a regime change.
The valuation angle is the hook. Semi cap equipment is trading at a 6-7x multiple discount to 2028 consensus. BofA projects WFE spend hits at least $250B in 2028 — that's two consecutive 30% CAGR years. Backed by TSMC/Intel capex hikes and a five-year $200B Samsung-Broadcom foundry deal. ASML's 2027/28 EPS estimates sit 6-7% above consensus on their numbers.
"The semiconductor sector trades at approximately a 3x discount to average 2028 consensus multiples, with semiconductor capital equipment stocks trading at a 6-7x discount."
(One data point worth watching: ASMI reports Tuesday — BofA looks for 11% EPS beat. That could be a near-term trigger for the sector if the print lands clean.)
Verdict: This is becoming a straight-up optical data center compounder, and the market hasn't fully repriced it yet. Q2 revenue of $168.8M cleared Stifel's bogey by ~2.3%. That's fine. The real story is the Q3 guide: $215M midpoint, up 27% sequentially and nearly 23% above where Street estimates were sitting. That's a beat-and-raise on steroids, especially when normal seasonal is -1.6%.
The optical DC revenue call-up is the headline. MXL now sees $210-230M in CY26 optical data center revenue, up from $150-170M previously. That's a ~50% raise at the midpoint. Keystone is ramping across 800G at multiple hyperscalers in US and Asia. Not a single-customer story anymore.
The Stifel $120 target is a 47x CY27 P/E multiple — aggressive, but they're betting on the 1.6T platform sampling for late CY27 revenue contribution. That's when the real TAM expansion kicks in.
"MaxLinear's 1.6T platform is currently sampling for late calendar year 2027 revenue contribution." — That's the next catalyst. 800G is delivering NOW. 1.6T is the 2027 narrative hook.
Needham raised to $100 from $60 (big jump) on the Q2 beat and Q3 guide. Both houses now aligned on the optical DSP demand trajectory. The stock pulling back after-hours on "sustainability concerns" is noise — PMs should be using that weakness to add.
The risk: It's already up 429% in a year. Multiple expansion is priced in. But the rate of change on the optical guide suggests this cycle has legs. Fading the after-hours dip is the play here.
Baird is sticking with Outperform and a $475 target (stock at $313, near 52-wk low, down 30% YTD). They're running a segment-by-segment deep dive, and this piece is specifically on Optimus/robotics. Their valuation for that business alone: ~$107/share, based on their pay package analysis from last fall. They're not pretending the numbers are clean — lots of "unknown variables" — but they're putting a flag in the ground anyway. The thesis: robotics is a long-dated call option the market is basically ignoring right now.
The firm acknowledges many unknown variables in its estimates for these long-dated initiatives.
Not a blockbuster call, but a reminder that even at these levels, the bull case doesn't need delivery growth alone — it needs optionality. Baird's just trying to quantify one piece of that optionality.
GLW IS GETTING MULCHED ON SECTOR UNWIND — NOT A COMPANY PROBLEM. Down ~20% in the past month vs. flat S&P. Underperformed by >30% relative in 30 days. That’s a positioning-driven flush, not a deterioration in the underlying business.
Oppenheimer out with a reiteration this morning — Outperform, $230 PT. They see a double beat in the Q2 print (tomorrow, July 28). The key call: optical revenue growing 28% YoY, led by enterprise network. And that enterprise segment should sustain mid-30s% YoY growth into H2, with Vera Rubin production ramping as additional tailwind.
"Oppenheimer views the current share price at under $150 as a compelling entry point for long-term investors."
BofA, Truist, and UBS all raised PTs recently — $243, $205, and $223 respectively — all pointing at optical strength, co-packaged optics, and solar growth. The bull case is intact. The market just decided to sell first, ask questions later.
Earnings call focus: capacity expansion timing, optical pricing, margin trajectory into H2. If GLW prints a beat and guides inline or better, this thing snaps back hard. The sector unwind is real, but GLW’s fundamentals are not the problem.
FLEX has been a monster — +137% IN THE PAST YEAR, now trading at ~48.7x P/E — but BofA is sticking with Buy into tomorrow's FQ1 print. They model $7.5B revenue / $0.91 EPS, inline. The bet is on continued cloud/power momentum and CPI segment acceleration through the year. That multiple is rich, but the narrative is margin expansion from prior investments and a mix shift into higher-value programs.
"We expect favorable mix and the recovery of prior CPI investments to support operating margin expansion of more than 100 basis points in the segment."
BofA also lays out FQ2: $7.77B rev / $0.99 EPS. The 82% six-month run has already priced in a lot, but the Street is still leaning positive into the print. Not a new call — just a reaffirmation ahead of the event. If they miss on guidance, that P/E gets ugly fast. But for now, the house sees compounding mix improvement and capital returns.
FORM is a long-term compounder trading through a near-term air pocket. Cantor stays Overweight at $175, but the call is nuanced: they see “meaningful value below $120” and aren’t constructive at $150+. Stock sits at $104 — a 35% haircut from the $160 high. That’s the tension.
“Earnings power of approximately $5 in CY28… at a 35x multiple supports the $175 fair value target.”
The bull case is intact: probe card market growth, share gains, DRAM/HBM demand. Cantor expects a beat-and-raise next week but warns supply constraints cap visibility on magnitude. They trust management execution (proven over recent quarters) but admit near-term numbers are “constrained.”
The rest of the Street has piled in with raised targets — Stifel to $135 (Hold), Northland to $118, Evercore to $155 (Outperform), Craig-Hallum to $175 (Buy). The Craig-Hallum thesis mirrors Cantor’s $5 EPS power on $1.6B revenue. That’s a long-duration bet, not a Q3 trade.
Chardan fires the starting gun with an initiation at Buy, $32 PT — 73% upside from $18.46. That's the headline, but the story here is bigger than one call. Terawulf has already ripped 257% in the past year, and the market is pricing in the AI datacenter pivot. Early mover is the right read: four leases locked (Core42, Fluidstack, Anthropic), 821 MW contracted (ex-Abernathy JV), and a 3.6 GW power portfolio across 5 sites. The Muskie site (1 GW) is next on the runway.
"Terawulf is an early mover in the transition toward AI and high-performance computing data center infrastructure."
The bull case writes itself: 250-500 MW of new critical IT load per year, Chardan estimates >$2.3B in annual net equity value creation. Gross margin 64% on $168M revenue (27% growth). The Anthropic deal alone (20-year, 401 MW IT capacity, $19B) validates the thesis. Needham raised to $33, Rosenblatt to $30. Even the NY moratorium on large datacenters doesn't touch already-permitted sites — WULF's existing footprints are shielded.
Bear caveat? The Abernathy sale (50.1% stake for ~$530M vs $450M invested) is a partial unwind, not a full conviction hold. And 73% upside from here implies the market hasn't fully discounted the pipeline. But for a multi-manager looking for structural AI infrastructure exposure at scale, WULF offers asymmetrical r/r with real lease velocity. Keep it on the radar.
VERDICT: THE DATA CENTER TAILWIND IS REAL, BUT THE REVENUE MISS REMINDS YOU THIS IS STILL A UTILITY. Bernstein bumps PT to $108 (from $107) on Q2 beat — $1.15 vs $1.13 consensus, +9.5% y/y. The real story is FPL’s large-load pipeline: 21 GW of interest, 12 GW in advanced discussions, and they now expect 8 GW in development by 2032 (up from 6 GW). Management telegraphed at least one large-load deal at FPL by year-end. That’s the rate-of-change narrative that matters — the AI / data center demand hook is now firming up with hard numbers.
But don’t ignore the other side: revenue printed $7.53B vs $8.19B forecast. That’s a horrid miss. Mizuho’s Neutral with a $95 PT is a reminder that the earnings beat was driven by cost discipline, not top-line acceleration. The stock trades 20x P/E — not cheap for a regulated utility, but the growth optionality from data center load and renewables backlog (35.1 GW, +2 GW q/q) keeps the bull case alive.
“Management expects to announce at least one large-load transaction at FPL by year-end.” — That’s the catalyst the market is waiting for. If it prints, multiple expansion follows. If not, the revenue miss will weigh.
UBS doubles down on the data center fiber buildout thesis. Reiterates Buy, $611 PT. DY has nearly doubled (68% YoY) to $445 and the story is aging well, not getting stale. Revenue up 30% LTM, Street modeling +37% for FY27.
"Data center fiber connections have emerged as one of the key growth pillars for Dycom and other telecom contractors over the next several years."
UBS built a bottoms-up model cross-referencing Fiber Broadband Association data – pegging a $19B contractor opportunity over 2025-29, with annual spend nearly tripling from ~$2.3B to ~$6B. Validates Dycom’s own $20B five-year estimate (which management hinted has upside).
Recent Q1 FY27 was a monster beat – EPS $4.42 vs $2.72 consensus, rev $1.965B vs $1.67B. That’s not just weather tailwinds from Cantor’s note; underlying demand is real. KeyBanc, Cantor, UBS all lifted PTs into the $610-654 range.
Bottom line: DY is effectively a levered play on the fiber backbone required for AI and cloud data center expansion. Rate of change is positive, execution is clean, and the market is still underappreciating the multiyear ramp. Keep the position.
QUANTUM COMPUTING GETS A STAMP OF APPROVAL. Benchmark re-enters the space with a Buy on RGTI, $25 PT — that's 64% upside from $15.24. The thesis isn't company-specific heroics; it's sector-level legitimacy building toward fault tolerance and universal Quantum Advantage. Not a winner-take-all game, they argue — better to take a portfolio approach in this early inning.
"Prior to the broad achievement of Quantum Advantage, the best strategy for investors may be to take a portfolio approach to investing in the sector." — Benchmark
That $4.7B market cap on $10M revenue (yes, you read that right) is pure narrative and optionality. But the narrative has tangible hooks: $100M CHIPS Act LOI (+ equity stake for the gov), Q1 FY26 revenue beat on multiple system sales, and the Cepheus 1-108Q now live on AWS and Azure. Cantor ($30), Craig-Hallum, Needham ($31) all echoing the same tune — but Benchmark's sector-wide re-entry is the signal PMs should watch. Not a one-off rating bump; it's a strategic bet that quantum's "real now" moment is accelerating.
Benchmark couldn't be more clear: they're bullish on the sector, not just the stock. Initiate at Buy, $60 PT (68% upside from $35.27). The call is less about IonQ's near-term execution and more about positioning for the quantum computing arc — a secular play with a long, capital-intensive tail. Mobley's note even suggests a portfolio approach to the space, not a single-name bet.
The numbers back the narrative: 335% revenue growth (LTM), $64.7M Q1 print that smashed consensus, raised FY guide. Plus the new Clavis XG Multiplex product (quantum key distribution on existing fiber) is a neat hook — "harvest now, decrypt later" threat is real and gives IonQ a security-adjacent angle.
"Quantum computing is not a winner-takes-all situation. In the early days of quantum computing, prior to the broad achievement of Quantum Advantage, the best strategy for investors may be to take a portfolio approach to investing in the sector."
Translation: Buy the basket, not just the leader. Benchmark's own $60 PT is mid-range vs. a $44.78-$100 analyst range — so they're not the most aggressive bull, but it's a clean entry point for PMs who want exposure without chasing the froth. (Stock's down 28% over six months — timing might work.)
BofA just threw its weight behind Fortinet — $200 PT from $180, Buy maintained. The call is simple: this is no longer a recovery story. It's a growth story. And the bar for execution just got higher. FTNT has already ripped 92% YTD (86% in six months — yes, that's real), so the easy money is long gone. BofA's new target at 45x FY27 EV/Sales (was 40x) reflects that shift.
"The stock has transitioned from a recovery story to a growth story, raising the bar for execution."
The broader analyst community is converging. Morgan Stanley finally crawled off the sidelines (Underweight → Equalweight, $133 PT). Cantor held Neutral at $165, but TD Cowen went aggressive at $215 with a Buy. The common thread: hardware strength, AI demand, and a platform consolidation tailwind that Fortinet is uniquely positioned to capture. Gross margins at 80% give them room to compete on price if needed.
What matters July 29 is sustain ability. Q2 will be a solid print — consensus expects that. The question is whether management can convince the Street that the 15%+ revenue growth trajectory holds into H2. Options market is pricing a 12% move post-earnings. For a stock that's already up 92%, that's either a re-rate or a reset. No in-between.
Bottom line: BofA is leaning into the narrative shift. But 45x EV/S on a hardware-heavy security name is a high multiple for a sleepy sector — you're paying for the transformation to a platform story. PMs who missed the rally will be tempted to chase. Just remember: the easy 86% is done. Now it's about conviction on the next leg.
Chardan fires the starting gun on CIFR with a Buy and $32 target. The whole thesis hinges on one differentiator: CIFR is the only bitcoin miner in its peer group that has actually closed a deal with AWS. That's not a pipeline story — that's a contracted revenue story, and in this market, that's everything.
Chardan uses a sum-of-the-parts framework, DCF-ing the secured Fluidstack and AWS leases, then layering in Bitcoin mining ops and net debt. The headline: 4.2 GW owned, another 2.8 GW in the pipeline, and a chunk of unallocated capacity sitting inside ERCOT's Batch Zero process. That's the swing factor — if Batch Zero clears, you get a value unlock on capacity the market is currently pricing at zero.
"Cipher Mining is the sole operator in its peer group to partner with Amazon Web Services."
The bull case is simple: AWS anchor tenant de-risks the compute pivot. The $810M notes offering at 6.000% due 2031 is expensive debt, but it funds the West Texas facility that AWS is signing a 15-year lease on. That's recurring, contracted cash flow — not hopium.
The bear case: At $23, the stock still needs the Batch Zero catalyst to justify the current multiple. One analyst says the InvestingPro Fair Value screen flags overvaluation here. That matters in a tape where capital is scarce and PMs are asking "what have you done for me lately?" versus "what might you do in 2028." The $23-$69 PT spread tells you conviction is low — even the bulls don't agree on the ceiling.
Bottom line: CIFR is a name to own if you believe ERCOT's Batch Zero process is real and on a near-term catalyst clock. Without it, you're paying up for a single AWS lease and a lot of optionality. Not a high-conviction position size — but it's the right kind of idiosyncratic risk for a sleeve that can handle the chop.
Hold the phone. SWKS is a muddled setup heading into tomorrow’s print (July 28). Benchmark stays at Hold, sees an inline June quarter ($925M / $1.03) but is more cautious on Sep guidance – Street EPS is $1.29, Benchmark models $1.24. The real signal is the September quarter outlook, not the rearview. KeyBanc’s downgrade to Sector Weight (citing smartphone headwinds and QRVO acquisition synergy fade) and RBC’s PT hike to $80 (Sector Perform) sum up the tug-of-war: stable biz, but no catalyst. Options market pricing a 9.1% move – feels like a coin flip.
"The September-quarter outlook will be the more important datapoint." – Cody Acree, Benchmark
Verdict: PEGA got shellacked after Q2 — stock down 19% in a week, scraping 52-week lows near $25. The AI uncertainty narrative is real and it's crushing near-term demand. But the valuation math is starting to get interesting for patient money. Net-net: messy setup, but the bull case rests on FCF yield and a low PEG ratio that scream undervalued if the growth deceleration is cyclical not structural.
The problem is straightforward: customers are delaying decisions because they can't figure out what AI means for their workflows. Q2 missed on both top and bottom line ($0.35 vs $0.43e, $420.7M vs $427.4M). Cloud revenue grew 28% y/y to $213.9M (51% of total) but still came up short vs Rosenblatt's $218M estimate. Term license revenue beat ($82M vs $77.8M), but that's a one-off — the ACV and FCF miss (second consecutive quarter) is what got the stock downgraded.
Bull case (DA Davidson, $32 PT but Buy): They see a 12% free cash flow yield and a PEG ratio of 0.25 — that's a deep value signal if you believe the AI confusion is transient. Analyst Lucky Schreiner maintained the Buy despite cutting the PT by 42%, basically saying "yes, near-term headwinds, but FCF upside in FY27 is real."
"PEG's strong 12% free cash flow yield and low PEG ratio of 0.25 suggest the stock may be undervalued at current levels." — DA Davidson
Bear case (Loop Capital, $25 PT, Hold downgrade; William Blair, Market Perform): The ACV miss for a second straight quarter is a pattern, not a blip. AI confusion isn't going away quickly — enterprises are still figuring out their AI strategies, and that means Pega's deal cycle gets stretched. Rosenblatt also cut to $47 but kept a Buy, which tells you the Street is split on whether this is a buying opportunity or a value trap.
The bottom line: PEGA is a binary bet on AI adoption timing. The FCF yield is compelling for PMs with a 12-18 month horizon. But if demand stays soft for another quarter, $25 becomes the ceiling, not the floor. Short-term catalysts are absent — wait for the next print to confirm stabilization.
Chardan slaps a Buy on HIVE with a $7.50 PT — 153% upside from $2.96. The pitch: pure-play Bitcoin mining plus an AI/GPU cloud colocation angle that they think is underexposed. Revenue surged 158% LTM and market cap sits just under $800M.
The thesis hinges on HIVE serving the Canadian sovereign AI push and the optionality to flip existing data center assets into higher-value GPU compute. Chardan uses a sum-of-the-parts — GPU services, colo leases, mining ops, net debt — to get to $7.50.
“HIVE offers exposure to Bitcoin mining operations and diversification into AI and high-performance computing workloads through its GPU cloud service platform and colocation business.”
Recent catalysts are real: a $130M exchangeable note offering (upsized to $130M from $100M, plus greenshoe) and a $220M GPU cloud contract with Bell Canada and Cohere. That’s a tangible revenue pipeline, not just vibes.
Risks? Bitcoin price correlation still dominates the tape (they mine it). And $793M market cap is no joke for a stock that’s basically a miner with an AI side-hustle. But the r/r is asymmetric if the AI cloud revenue ramps. Worth watching the next Bitcoin halving impact and whether the GPU contracts get re-upped at higher margins.
Check Point remains a value trap narrative until they prove subscription growth can re-accelerate. BofA nudges PT to $140 from $120 but stays Neutral — not a vote of confidence. Stock is DOWN 29% YTD at $130.57, P/E of 12.9, 88% gross margins. Cheap for a reason: revenue growth anemic (BofA models +1.5% y/y Q2), subscription growth below street at 11.4% vs 12.2% consensus. The market wants to see management show a path to faster topline, not just a cheap multiple.
"Investors are looking for evidence that management can demonstrate a path to faster topline growth as Check Point enters the second quarter of 2026."
Divergent analyst views muddy the picture. Guggenheim upgraded to Buy with a $188 PT (call options volume hit highest since July 2021). Raymond James downgraded to Market Perform — channel checks deteriorating, turnaround timing in doubt. Cantor sits Neutral at $150. The bull case hinges on demand firming into 2027, the bear case says this is a structural growth problem, not a cyclical one. No clear edge here until the Q2 print gives us something to lean on.
Cantor holds Neutral at $132 — stock already at $142, so that target is dead on arrival. Truist is the real signal here: raised to $182 from $155, Buy. Two different worlds on the same name. Cantor sees multiple expansion as the only driver and thinks subscription ARR is conservatively set (second-half weighted, non-linear). They like the recast of Enterprise Support into subscription ARR to backstop the $190M FY27 guide. Gross margins at 81% and cloud gross above 70% give them cover. Truist clearly thinks there’s more torque from cyber resilience + AI tailwinds + the Azure native partnership.
"The new price target reflects a valuation of 4 times enterprise value to calendar 2027 estimated sales." (Translation: Cantor isn’t paying up for the narrative, even if the business is solid.)
Bottom line: The Truist upgrade is the actionable call. Cantor’s Neutral is just a math exercise on current valuation. If you’re a PM looking at CVLT, you’re buying Truist’s thesis or passing. No middle ground at this price.
Three new analyst initiations this morning — all positive, all buying the micro-mobility thesis. Jefferies leads with Buy and $40 PT, KeyBanc Overweight at $33, Evercore Outperform at $40. Street sees LIME as the clear category king: 27% total market share (35% of dockless), vertically integrated ops driving better deployment and density. Revenue run-rate $928M, but still printing -$6.57 EPS. The bull case hinges on existing city growth moderating to 9% fleet CAGR / 16% revenue CAGR (from mid-to-high teens / low-to-mid twenties historically) plus a TAM that roughly doubles with new city entries over next five years.
“LIME’s vertically integrated operations enable more efficient vehicle deployment and utilization, resulting in higher network density.” — Jefferies
IPO demand was 6x oversubscribed, stock opened at $27 on the Nasdaq — currently $28.23, within a stone’s throw of the 52-week high ($28.99). Not pricing in perfection yet, but r/r is compressing as the narrative shifts from “unprofitable scooter company” to “last-mile infrastructure bet.” Worth watching fleet growth cadence in the Q2 print.
UBS threw cold water on the BYIT rally. Downgraded to Sell from Neutral, and the catalyst is structural – Microsoft is gutting the reseller incentive model. Starting October 2026, base incentives on Office 365 drop 500bps to 15%, Azure consumption incentives cut 50bps to 7%. They’re shifting to “Growth Margins” tied to new customer acquisition and seat expansion, not renewals. That’s a direct hit to Bytes’ bread-and-butter renewal book (~50% of gross profit from Microsoft incentives/mark-up).
"We see risks as underappreciated at current levels… the incentive changes will be net negative, and later-year risks are rising."
UBS raised PT to 365p from 305p (trading at ~18x CY26 P/E, 60% premium to a competitor with 60% MSFT exposure), but cuts FY28/29 EBIT by 3-4%. Shares are +19% YTD. MSFT reports tomorrow – expect CapEx guide up 61% in FY27. That’s the macro headwind: Microsoft squeezes partners to fund its own buildout. The 1-turn discount to MSFT isn’t enough compensation given the structural margin erosion. Not chasing this one.
Barclays cut PT to $8 from $18 (Equalweight) but the stock’s already at $5.49 — basically pricing in a restructuring. The cut follows a new services deal with Bluesphere Ventures for NY storage projects (Con Edison territory, Local Law 97). That’s real: higher-margin software/consulting revenue vs. hardware treadmill. But the headline number is the cash burn. Q1 revenue dropped to $29M (-11% YoY), though adjusted EBITDA flipped to +$2M (a $7M improvement). AIONA AI platform and Chile solar+storage project are nice narrative tics, but not moving the needle.
“The award highlights Stem’s growing focus on higher-margin software and managed services offerings, leveraging its operational expertise to support investment decisions and project development in storage markets.”
The pivot makes sense — turning operating data into advisory revenue. But with debt and cash burn still on the table, this is a show-me story. The $8 PT implies 45% upside from here, but the 52-week low was $5.45 — market’s already discounting failure. If they can scale services without burning more cash, r/r improves. If not, this is a sub-$5 name. Not a conviction call, but worth watching the quarterly cash trajectory.
Mizuho bumps PT to $114 from $105, but stays Neutral. Stock already at $113, just 2% shy of the new target and 3% off a 52-week high. The hook: NYC reliability report pushes the first transmission deficiency to 2033 (one year later than the January filing), but long-term needs keep compounding — 675MW in 2036, then 2.3GW by 2045. That means incremental capex, but it's back-end loaded. Marginal accretion starts late 2020s at best.
"The incremental opportunities presented in the report would be marginally accretive in the late 2020s to early 2030s."
The other side: Goldman Sachs maintains Sell, PT $105, calling the $2B ATM equity program a sign of financing overhang. Dividend yield is a cushy 3.14% (51-year streak), but the r/r is tight when you're trading at PT with a Neutral rating. Not a catalyst-rich setup near the highs — you're paying for long-dated grid build that's still a decade away from hitting the P&L in a meaningful way.
Verdict: Stock is pinned at 52-week lows ($65.56) while the Street screams cheap. Multiple analysts see the Delivery Hero deal as unlocking delivery TAM and Uber One penetration — but the market is pricing in something else entirely.
Citizens (Market Outperform, $100 PT) is the latest to bang the table, pointing to 9.4x 2027 EBITDA — cheap on an absolute basis, but the sum-of-parts implies Mobility is only getting ~7x. That's a massive discount to DoorDash. The $100 target uses 14x, which is an acknowledgment that this isn't a broken model, just a hated one.
The Delivery Hero acquisition is the immediate catalyst: adds 24 markets where Uber already has mobility operations, creates a natural cross-sell for Uber One. Street consensus remains Strong Buy — TD Cowen ($118), Guggenheim ($125), Jefferies ($110) all reiterating Buy on AV expansion, Mobility bookings growth, and what they see as a mispriced delivery business.
“The Delivery Hero acquisition increases Uber’s exposure to delivery operations and enables greater penetration of Uber One.”
The bear case: stock down 35% from highs despite no fundamental breakdown. Market might be looking at AV liability, regulatory overhang, or just punishing any name that touched $100+ on momentum. R/R here is asymmetric if you believe the EBITDA trajectory — but PMs should remember that "cheap" doesn't trigger until the narrative turns.
Verdict: BofA stays Buy/$350, but the real signal here is the battle between the "financing extended cycle" bull case and the "financial engineering" bear case. The dual AI model strategy (open-source + OpenAI backing) maximizes GPU demand across frontier labs (20% of DC sales) and the long tail. Bear case: NVDA's forward P/E below 20x and PEG at 0.5x — the market is already pricing in discount for financing-assisted demand. Bull case: access to capital and power extends the buildout beyond what balance sheets alone could fund. That's the crux.
"Frontier labs account for approximately 20% of Nvidia’s data center sales, with the vast majority coming from other sources."
The KeyBanc target bump to $330 and the $250B OpenAI financing chatter (CoreWeave/Nebius up) are noise relative to this structural tension. NVDA trades 31x trailing — that's not expensive for 71% revenue growth, but the market is asking "how much of this is real demand vs. vendor financing?" Your move, PMs.
NEEDHAM GOES TO $530, BUY MAINTAINED. The call is purely a numbers roll — updated AI wafer demand model plus 2026Q2 print baked into forward estimates. PT at 18x 2028 EPS (stock currently trades 27.4x, PEG 0.51). They’re modeling 40% and 24% top-line growth in 2027 and 2028, respectively. Capex steps up to $80B in 2027, then $90B in 2028 — that implies fab equipment spending +30% next year and +6% the year after. The real kicker is in advanced packaging: they see significant CoWoS spending acceleration in H2 2026 and a breakout for HBM packaging spend in 2027.
"We raised our CoWoS and HBM capacity forecast, anticipating strong upside in CoWoS spending in the second half of 2026 and a breakout year in HBM packaging spending in 2027."
Implication for the broader equipment complex: Needham explicitly calls out KLA, Nova, Onto Innovation, and Camtek as beneficiaries of the TSM capex ramp. That’s the trade-through thesis — if TSM spends, the tool makers get paid. No bear case in this note, but the stock’s current multiple implies investors are already pricing in some of this growth. The PEG of 0.51 suggests it’s not egregiously expensive vs forward earnings power, but anything less than execution on that $80B+ spend and the narrative flips hard.
RMBS — Memory interface content growth is the story, not server units. Product revenue +22% YoY, Q3 guide implies ~20% — that's structural, not cyclical. MRDIMM (4x silicon content/module) is a 2027 catalyst, but near-term DDR5 chipset share gains are already driving. Hyperscaler HBM design win confirms RMBS is moving up the stack. Verdict: Accelerating share gains, not yet priced for the 12-18 month tailwind.
CDNS — Record $8.1B backlog in a low renewal year tells you everything. Core EDA +18%, semi IP >40%, system design +37%. This isn't billing timing — it's design consumption. Hyperscaler custom silicon programs are proliferating, and CDNS is embedded in those flows. Taking share from SNPS in digital, signoff, analog, IP. Verdict: Structural acceleration, underappreciated multi-year tailwind.
CXMT — IPO surged +466% to $488B — bigger than Intel, for a DRAM player with 7.6% share. That's retail speculation, not fundamentals. Real story: competitive threat is years away (no EUV, cost disadvantage, no HBM logic die), but the MATCH Act risk is real. PC vendors locking supply through 2027 confirms tightness. Verdict: Explosive speculation, fundamental impact years out — regulatory risk is the near-term catalyst.
SKHY — Meritz forecasts Q2 pretax profit ~KRW 100tn — would be the highest quarterly profit ever by a global tech company. CEO confirms 'unbelievable' demand conversations with Jensen, Hock Tan, Altman, Amodei. ADR broke below IPO price on semiconductor sell-off, not fundamental. Verdict: Temporary mispricing. HBM thesis unchanged. Buy the dip.
MU — Memory stocks trade at ~5x earnings. Nomura calls it mispriced by an order of magnitude. DRAM orders stretch through 2027. AI makes memory a goodput enabler — joint MU/Meta whitepaper quantified the DRAM bottleneck at 38x slowdown when data spills to SSD. DDR4 prices +80% in H1 — AI demand is structural, not cyclical. Verdict: Deep value in a structural growth story. Market hasn't repriced yet.
AAPL — Reclaimed market cap lead from NVDA but that's a sentiment indicator, not fundamental. CQ3/CQ4 estimates too high — rising semiconductor costs are a margin headwind. Foldable + AI Siri is 2027-2028 optionality. Verdict: Near-term risk, long-duration call option. Not a core position here.
AVGO — Samsung signed $200B MOU to make chips for Broadcom — memory and logic. Validates the sourcing strategy. Bailly CPO (51.2T) shipping in small volumes, Meta completed verification. Hyperscaler custom silicon is a multi-year tailwind. Verdict: Step change in manufacturing optionality. CPO entering production phase.
MRVL — Google developing custom Gemini inference chip — Marvell is the likely partner. Initial production 2027. Major design win if confirmed. Hyperscaler custom silicon acceleration benefits MRVL across networking and compute. Verdict: Long-term catalyst, not near-term. But worth the optionality.
ADI — 73% gross margins reflect genuine pricing power from design-in platforms. Linear/Maxim acquisitions created system-level breadth. Empower acquisition targets AI power delivery — early but real. China domestic analog competition is the structural risk to watch. Verdict: Moat is defensible. Leadership succession is noise, not signal.
AMKR — Expected to crush earnings as AI CPU boom beneficiary. CoWoS packaging is the bottleneck for US-made GB300. AMKR is in the most constrained part of the AI supply chain. Verdict: Structural bottleneck play. Rates accelerating.
F5 — Q3 beat: revenue +11%, system growth +32%, FY26 guide raised to 9-10%. AI security customer count doubled. Inference traffic going enterprise — this is real. Verdict: Accelerating. The shift from training to inference/security layer is underappreciated.
STM / ON / WOLF / IFNNY — Nvidia's 800VDC power architecture is the SiC catalyst. Delta's $2B LTA with Infineon validates demand. STM and ON are well-positioned. WOLF has execution risk but turnaround potential. Verdict: SiC demand accelerating for data center power. IFNNY is the cleanest play.
CLS / SANM — Both trade at moderate 2027 EPS multiples after giving back May/June gains. AI infra tailwinds clear over 12-18 months. Verdict: Stable entry points, not catalysts.
ASM — BofA expects Q2 EPS beat by 11%. WFE cycle beneficiary driven by AI and advanced nodes. Verdict: Accelerating semicap cycle. ASM is leveraged.
MTK — TPU revenue expected to ramp strongly in Q4 2026, potentially >50% of revenue by end of next year. Major new growth driver. Verdict: Transformation underway. Underappreciated.
Hearing China has begun mass-producing domestic DUV lithography tools — 5 units in 2024, 20 by 2027. Throughput and overlay accuracy gaps remain far below displacement thresholds. Near-term noise for ASML, not a structural threat.
Word is NVDA's $5B SSI investment and $750B deal pipeline (Hynix $500B, OpenAI $250B, SSI, Thinking Machines) is crystallizing the circular finance narrative. Market split on whether this is demand validation or vendor-financed bubble formation. Keep an eye on IG CDS spreads — AI CDS basket hit another record wide.
Channel checks suggest Kimi K3's KV cache compression is memory positive — makes NAND offload economically viable. Model scale still demands more HBM and scale-up networking. The bear case has the sign wrong.
Hearing Chinese open-source AI models are strategically favorable for US CSPs and NVDA but threaten closed labs (OpenAI, Anthropic). US benefits from deploying Chinese models on US infrastructure, capturing inference revenue.
Word is GLM, Kimi, and MiniMax are adopting Alibaba's in-house PPU 1.5 for inference. Signals Chinese model labs moving toward domestic accelerators for inference workloads. Read-through for NVDA's China inference revenue.
Channel checks suggest SSI's shift from TPU-only to NVIDIA Vera Rubin is a major compute-platform commitment. NVDA's $5B investment gives SSI 10x compute scaling over 12 months. Locks in frontier-lab customer on next-gen silicon.
Hearing GOOG GCP print at 82% YoY (~79% ex-Wiz) is the first hard evidence the capex cycle is clearing an ROI hurdle. Supports the bull case that AI infrastructure spend is demand-backed, not speculative.
Word is MSFT Azure capacity ramping hard — 1.1GW online in CQ2, 1.5GW expected in CQ4. FY2027 server procurement may increase ~50K units versus FY2026. Azure is eating.
Channel checks suggest AMD's warrant deals with OpenAI and Meta function as compute rebates — up to 105% discount. A creative way to lock in demand without lowering list price. Watch for margin implications.